outcomes research

Department

Observation Following Subcutaneous Trastuzumab Administration Unnecessary

02/13/2017

JCP Editors

Extended observation for adverse reactions following subcutaneously administered trastuzumab (Herceptin, Genentech/Roche) serves as an unnecessary use of health care resources, according to the results of a...

...

02/13/2017

Journal of Clinical Pathways

Department

Symptoms of Menopause Influence Tamoxifen Adherence Rates

02/13/2017

JCP Editors

Common menopausal symptoms such as nausea and headaches can be used as predictive tools for adherence to the aromatase inhibitor tamoxifen, according to an analysis of data from the International Breast Cancer...

...

02/13/2017

Journal of Clinical Pathways

Research in Review

Radiotherapy Combined With Delayed Surgery Reduces Adverse Effects of Rectal Cancer Treatment

02/13/2017

JCP Editors

Short-course preoperative radiotherapy combined with delayed surgery reduces the adverse effects of rectal cancer surgery while maintaining its efficiency, according to a study published in The Lancet (published...

...

02/13/2017

Journal of Clinical Pathways

Interview

Using Emotion to Guide Palliative Treatment

02/13/2017

JCP Editors

Many health care providers and patient advocates have worked diligently to alter the perception of palliative care from something that occurs strictly at the end of life to an ongoing course of action for symptom...

Many...

02/13/2017

Journal of Clinical Pathways

Research in Review

Chemotherapy May Be Overused Among Patients With Colon Cancer

02/09/2017

JCP Editors

Chemotherapy may be overused among young and middle-aged patients with colon cancer, according to a study published in JAMA Surgery (published online January 25, 2017; doi: 10.1001/jamasurg.2016.5050). ----- Related...

...

02/09/2017

Journal of Clinical Pathways

Research in Review

Comparative Effectiveness Study Identifies Best Therapy Regimens for Patients With NSCLC

02/02/2017

JCP Editors

A new study comparing first-line therapies for patients with advanced non-small cell lung cancer (NSCLC) suggests a survival advantage of one treatment regimen in younger patients, published in the Journal of Managed...

A new...

02/02/2017

Journal of Clinical Pathways

Research in Review

ADT Not Associated With Increased Risk of Dementia for Patients With Prostate Cancer

02/01/2017

JCP Editors

Treating advanced prostate cancer with androgen deprivation therapy (ADT) does not increase risk of Alzheimer’s disease, according to research published in the Journal of Clinical Oncology. ADT is prescribed to men...

...

02/01/2017

Journal of Clinical Pathways

Research in Review

Less-Frequent Dosing Noninferior to Standard Dosing of Bone-Modifying Agent for Breast Cancer

01/30/2017

JCP Editors

A less-frequent dosing schedule of a bone-modifying agent (BMA) for treatment of skeletal-related events related to metastatic breast cancer is noninferior to standard dosing, according to research published in JAMA...

A...

01/30/2017

Journal of Clinical Pathways

Research in Review

Induction Therapy With Clofarabine Shows No Survival Benefit for AML

01/16/2017

JCP Editors

Adding clofarabine to standard induction therapy shows no effect on survival for patients with newly diagnosed acute myeloid leukemia (AML), according to a study published in Blood. Standard induction treatment with...

Adding...

01/16/2017

Journal of Clinical Pathways

Research in Review

Three-Drug Regimen Does Not Improve Prostate Cancer Survival

01/05/2017

JCP Editors

Progression-free survival (PFS) is not improved in patients with metastatic castration-resistant prostate cancer (mCRPC) when enzalutamide is added to abiraterone acetate with prednisone, compared with abiraterone...

...

01/05/2017

Journal of Clinical Pathways